- Home
- APVO vs CMND Comparison
APVO vs CMND Comparison
Compare APVO & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- CMND
- Stock Information
- Founded
- APVO 2016
- CMND 2017
- Country
- APVO United States
- CMND Canada
- Employees
- APVO N/A
- CMND N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- APVO Health Care
- CMND Health Care
- Exchange
- APVO Nasdaq
- CMND Nasdaq
- Market Cap
- APVO 4.9M
- CMND 5.3M
- IPO Year
- APVO N/A
- CMND N/A
- Fundamental
- Price
- APVO $1.78
- CMND $0.97
- Analyst Decision
- APVO
- CMND
- Analyst Count
- APVO 0
- CMND 0
- Target Price
- APVO N/A
- CMND N/A
- AVG Volume (30 Days)
- APVO 16.3M
- CMND 2.0M
- Earning Date
- APVO 11-06-2025
- CMND 09-11-2025
- Dividend Yield
- APVO N/A
- CMND N/A
- EPS Growth
- APVO N/A
- CMND N/A
- EPS
- APVO N/A
- CMND N/A
- Revenue
- APVO N/A
- CMND N/A
- Revenue This Year
- APVO N/A
- CMND N/A
- Revenue Next Year
- APVO N/A
- CMND N/A
- P/E Ratio
- APVO N/A
- CMND N/A
- Revenue Growth
- APVO N/A
- CMND N/A
- 52 Week Low
- APVO $1.32
- CMND $0.80
- 52 Week High
- APVO $381.10
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- APVO 53.33
- CMND 41.98
- Support Level
- APVO $1.41
- CMND $0.98
- Resistance Level
- APVO $1.49
- CMND $1.05
- Average True Range (ATR)
- APVO 0.18
- CMND 0.07
- MACD
- APVO 0.04
- CMND -0.01
- Stochastic Oscillator
- APVO 35.04
- CMND 12.72
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.